ENTERO HEALTHCARE SOLU L (ENTERO)

NSE: ₹1,139.50
BSE: ₹1,140.50
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 992.63 1,034.18 1,097.04 1,300.69 1,359.00 1,339.06 1,403.82 1,570.95 1,706.52 1,909.93
YOY Revenue Growth % - - - - 36.91% 29.48% 27.96% 20.78% 25.57% 42.63%
Other Income 1.79 9.15 13.44 11.28 7.50 7.29 5.83 4.79 4.61 4.01
Total Income 994.42 1,043.33 1,110.47 1,311.97 1,366.49 1,346.35 1,409.64 1,575.74 1,711.13 1,913.94
Total Expenses + 986.10 1,029.76 1,083.17 1,277.20 1,327.06 1,309.12 1,373.28 1,531.11 1,662.55 1,855.99
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 39.89 37.93 43.57 50.07 53.39 52.02 57.56 59.21 63.98 64.76
Other Expenses 21.71 25.80 26.23 29.65 30.00 29.84 31.94 39.53 40.84 56.62
Operating Profit 6.53 4.41 13.86 23.50 31.94 29.93 30.54 39.83 43.97 53.94
OPM % 0.7% 0.4% 1.3% 1.8% 2.4% 2.2% 2.2% 2.5% 2.6% 2.8%
Profit Before Tax + 8.32 13.56 27.30 34.78 39.44 37.23 36.36 44.63 40.40 57.95
Tax Expense 1.34 -7.62 6.77 8.74 9.99 5.80 6.13 8.03 6.52 12.82
Tax % 16.1% -56.2% 24.8% 25.1% 25.3% 15.6% 16.9% 18% 16.1% 22.1%
Profit After Tax 6.98 21.18 20.53 26.03 29.45 31.42 30.23 36.60 33.88 45.13
EPS (Basic) 1.91 5.73 4.62 5.43 5.85 5.91 6.39 7.26 6.35 6.44

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 6,591.21 5,095.78 3,922.31
YOY Revenue Growth % 29.35% 29.92% -
Other Income 19.24 39.51 14.41
Total Income 6,610.45 5,135.29 3,936.72
Total Expenses + 6,422.94 4,996.55 3,901.17
Employee Benefit Expense 245.50 199.04 151.15
Other Expenses 168.93 115.72 88.97
Operating Profit 168.28 99.23 21.14
OPM % 2.6% 1.9% 0.5%
Profit Before Exceptional 187.51 138.74 35.55
Exceptional Items -8.18 0.00 0.00
Profit Before Tax + 179.34 138.74 35.55
Tax Expense 33.50 31.31 -4.24
Tax % 18.7% 22.6% -11.9%
Profit After Tax 145.84 107.43 39.80
EPS (Basic) 26.44 21.80 10.81

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 1,091.83 626.81 334.00
Property, Plant & Equipment 103.11 132.06 93.08
Capital Work in Progress 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00
Goodwill 749.09 423.96 192.82
Other Intangible Assets 8.53 3.27 3.44
Current Assets + 2,503.13 2,075.71 2,010.98
Inventories 841.68 659.78 421.16
Trade Receivables 1,212.44 830.36 615.40
Cash and Cash Equivalents 146.88 229.28 147.65
Current Investments 129.89 57.56 0.00
LIABILITIES & EQUITY
Total Equity 1,752.55 1,770.36 1,641.38
Equity Share Capital 43.51 43.51 43.49
Other Equity 1,645.10 1,680.64 1,594.56
Non-Current Liabilities 260.15 87.14 101.65
Current Liabilities 1,587.57 845.02 601.94
Total Liabilities 1,847.72 932.16 703.59

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities 96.20 -76.86 -36.61
Cash from Investing Activities -303.06 219.80 -705.12
Cash from Financing Activities 123.66 -73.66 862.94
Net Increase/Decrease in Cash -83.20 69.28 121.21